Jubilant Pharmova share price has zoomed 6% and is presently trading at Rs 898.2.
Meanwhile, the BSE HEALTHCARE index is at 41,408.9 (up 0.6%).
Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 11.3%) and AARTI DRUGS (up 5.4%).
SUVEN PHARMACEUTICALS (down 2.7%) and FORTIS HEALTHCARE (down 2.3%) are among the top losers today.
Over the last one year, Jubilant Pharmova has moved up from Rs 431.5 to Rs 898.2, registering a gain of Rs 466.8 (up 108.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,408.9, registering a gain of 48.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 127.6%), Jubilant Pharmova (up 108.2%) and GSK Pharma (up 107.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,484.5 (up 0.1%).
The top gainers among the BSE Sensex today are Tata Steel (up 1.4%) and NTPC (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 24,570.0 (up 0.1%). Hindalco and BPCL are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 80,484.5, registering a gain of 15,082.5 points (up 23.1%).
Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.
For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.
The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 27.4.
Equitymaster requests your view! Post a comment on "Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!